Abstract
Inflammatory pseudotumors (IPTs) are rare, benign lesions that can mimic malignancy. We present a case of an 81-year-old woman with a 4 cm IPT in the Spiegel lobe (Segment 1) of the liver. Despite initial conservative treatment and biopsy suggesting a benign fibrous lesion, surgical resection was performed to definitively rule out malignancy. The patient recovered fully and remained recurrence-free at 10 months.
Introduction
Inflammatory pseudotumors are characterized by a complex histological mix of inflammatory cells and fibrous tissue. While more common in the lungs, hepatic occurrences are rare. Locating such a tumor in the Spiegel lobe—a deep, anatomically complex portion of the liver—presents significant diagnostic and surgical challenges. This case highlights the "diagnostic masquerade" where benign IPTs present with systemic symptoms and imaging features that closely resemble hepatocellular carcinoma (HCC) or metastatic disease.
Case Presentation and Diagnostic Workflow
An 81-year-old woman presented with a five-day history of high fever (>39°C) and upper abdominal pain, unresponsive to antibiotics. Laboratory tests indicated severe inflammation, with a C-reactive protein (CRP) level of 20.9 mg/dL and a white blood cell count of 15,500/µL.
Initial abdominal ultrasound identified a 4 cm hypoechoic lesion within the Spiegel lobe.
Further multi-modal imaging was employed to characterize the mass. Computed tomography (CT) showed a moderate-to-high-density area in the arterial phase and a low-density area in the Spiegel lobe on the delayed phase.
Magnetic resonance imaging (MRI) revealed a faint low-intensity lesion on T1-weighted imaging and a moderate-to-high-intensity lesion on T2-weighted imaging. Angiography indicated slight hypervascularity in the region.
Management and Pathological Findings
An ultrasound-guided liver biopsy showed hepatic parenchyma replaced by dense hyalinized fibrous tissue and inflammatory cells. Although these findings suggested a benign lesion, the tumor's size remained unchanged despite antibiotic therapy. Given the risk of sampling error in fibrous tumors—where small biopsies might miss malignant pockets—malignancy could not be excluded.
A Segment 1 resection was performed. Macroscopic examination of the specimen revealed a gray, fibrotic, solid tumor that was well-circumscribed but non-encapsulated. Microscopically, the tumor exhibited a marked fibrotic background infiltrated by lymphocytes, plasma cells, histiocytes, and reactive spindle cells, consistent with a hyalinized sclerosing type of IPT.
Discussion
The rarity of IPT in the Spiegel lobe adds surgical complexity due to its deep position. Differentiating IPT from HCC is critical; while HCC typically shows arterial hyperdensity followed by "washout," IPTs may show fading radiological findings or specific capsular enhancement over time.
The "biopsy dilemma" remains central to management. Because IPTs can occasionally recur or even metastasize, and biopsy samples are limited, surgical resection often serves as a necessary "fail-safe" when a diagnosis is uncertain. In this case, the patient's uneventful recovery and 10-month disease-free interval justify the aggressive surgical approach.
Conclusion
This case underscores the importance of considering IPT in the differential diagnosis of liver masses, even in rare locations like the Spiegel lobe. While conservative management is sometimes possible, surgical resection remains the gold standard for definitive diagnosis and treatment when malignancy cannot be ruled out.
Summary updated